Header Logo

Connection

Assiamira Ferrara to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Assiamira Ferrara has written about Diabetes Mellitus, Type 2.
Assiamira Ferrara
Connection Strength
8.392
Diabetes Mellitus, Type 2
  1. Reach, acceptability, and perceived success of a telehealth diabetes prevention program among racially and ethnically diverse patients with gestational diabetes: the GEM cluster-randomized trial. Transl Behav Med. 2022 Jul 18; 12(7):793-799.
    View in: PubMed
    Score: 0.503
  2. Uptake of guideline-recommended postpartum diabetes screening among diverse women with gestational diabetes: associations with patient factors in an integrated health system in USA. BMJ Open Diabetes Res Care. 2022 06; 10(3).
    View in: PubMed
    Score: 0.498
  3. Incidence and predictors of type 1 diabetes among younger adults aged 20-45 years: The diabetes in young adults (DiYA) study. Diabetes Res Clin Pract. 2021 Jan; 171:108624.
    View in: PubMed
    Score: 0.450
  4. Comparative Effectiveness of 2 Diabetes Prevention Lifestyle Programs in the Workplace: The City and County of San Francisco Diabetes Prevention Trial. Prev Chronic Dis. 2020 05 28; 17:E38.
    View in: PubMed
    Score: 0.434
  5. A Randomized Study of Values Affirmation to Promote Interest in Diabetes Prevention Among Women With a History of Gestational Diabetes. Med Care. 2019 07; 57(7):528-535.
    View in: PubMed
    Score: 0.407
  6. Risk of Type 2 Diabetes Mellitus following Gestational Diabetes Pregnancy in Women with Polycystic Ovary Syndrome. J Diabetes Res. 2017; 2017:5250162.
    View in: PubMed
    Score: 0.366
  7. Leveraging EHRs for patient engagement: perspectives on tailored program outreach. Am J Manag Care. 2017 Jul 01; 23(7):e223-e230.
    View in: PubMed
    Score: 0.354
  8. The impact of telephonic wellness coaching on weight loss: A "Natural Experiments for Translation in Diabetes (NEXT-D)" study. Obesity (Silver Spring). 2017 02; 25(2):352-356.
    View in: PubMed
    Score: 0.345
  9. Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014. Am J Obstet Gynecol. 2017 Feb; 216(2):177.e1-177.e8.
    View in: PubMed
    Score: 0.337
  10. Lifestyle behaviors and ethnic identity among diverse women at high risk for type 2 diabetes. Soc Sci Med. 2016 07; 160:87-93.
    View in: PubMed
    Score: 0.328
  11. Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
    View in: PubMed
    Score: 0.319
  12. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.310
  13. Response to comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303. Diabetes Care. 2014 Dec; 37(12):e280.
    View in: PubMed
    Score: 0.296
  14. A call to increase physical activity among women of reproductive age: is it possible? JAMA Intern Med. 2014 Jul; 174(7):1056-7.
    View in: PubMed
    Score: 0.288
  15. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
    View in: PubMed
    Score: 0.284
  16. Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI Study. Diabet Med. 2014 Jul; 31(7):862-7.
    View in: PubMed
    Score: 0.283
  17. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care. 2014; 37(5):1296-303.
    View in: PubMed
    Score: 0.281
  18. A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study. BMC Pregnancy Childbirth. 2014 Jan 15; 14:21.
    View in: PubMed
    Score: 0.279
  19. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.275
  20. A pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized control trial. Diabetes Care. 2011 Jul; 34(7):1519-25.
    View in: PubMed
    Score: 0.231
  21. Strategies for diabetes prevention before and after pregnancy in women with GDM. Curr Diabetes Rev. 2011 Mar; 7(2):75-83.
    View in: PubMed
    Score: 0.228
  22. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 2001 Jul; 24(7):1144-50.
    View in: PubMed
    Score: 0.117
  23. Evaluating the Use of Electronic Health Records for Type 2 Diabetes Surveillance in 2 California Counties, 2010-2014. Public Health Rep. 2017 Jul/Aug; 132(4):463-470.
    View in: PubMed
    Score: 0.088
  24. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 1996 Jan; 81(1):59-64.
    View in: PubMed
    Score: 0.080
  25. Is insulin really a heart disease risk factor. Diabetes Care. 1995 Sep; 18(9):1299-304.
    View in: PubMed
    Score: 0.078
  26. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.075
  27. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2003 Aug; 26(8):2294-9.
    View in: PubMed
    Score: 0.068
  28. Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol. 2013 Feb 20; 13:12.
    View in: PubMed
    Score: 0.066
  29. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7(1):e29202.
    View in: PubMed
    Score: 0.061
  30. Study of Women, Infant Feeding, and Type 2 diabetes mellitus after GDM pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health. 2011 Dec 23; 11:952.
    View in: PubMed
    Score: 0.060
  31. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011 Apr; 34(4):916-22.
    View in: PubMed
    Score: 0.057
  32. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.057
  33. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.056
  34. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.
    View in: PubMed
    Score: 0.055
  35. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes. J Womens Health (Larchmt). 2009 Dec; 18(12):2065-70.
    View in: PubMed
    Score: 0.052
  36. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.048
  37. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.045
  38. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care. 2005 Apr; 11(4):262-70.
    View in: PubMed
    Score: 0.038
  39. Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study: response to Delea et al. Diabetes Care. 2004 Mar; 27(3):850-1; author reply 852-3.
    View in: PubMed
    Score: 0.035
  40. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000 Apr; 23(4):477-83.
    View in: PubMed
    Score: 0.027
  41. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999 Jun; 22(6):938-43.
    View in: PubMed
    Score: 0.025
  42. Wellness Coaching for People With Prediabetes: A Randomized Encouragement Trial to Evaluate Outreach Methods at Kaiser Permanente, Northern California, 2013. Prev Chronic Dis. 2015 Nov 25; 12:E207.
    View in: PubMed
    Score: 0.020
  43. Lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus and borderline hyperglycemia: a population-based study. Metabolism. 1995 Oct; 44(10):1293-7.
    View in: PubMed
    Score: 0.020
  44. Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation. J Clin Endocrinol Metab. 1993 Aug; 77(2):409-12.
    View in: PubMed
    Score: 0.017
  45. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes. 1992 Apr; 41(4):521-6.
    View in: PubMed
    Score: 0.015
  46. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care. 2012 Jan; 35(1):50-6.
    View in: PubMed
    Score: 0.015
  47. Effect of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive, non-insulin dependent diabetics. Eur J Clin Pharmacol. 1989; 36(1):1-4.
    View in: PubMed
    Score: 0.012
  48. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001 Jul; 111(1):1-9.
    View in: PubMed
    Score: 0.007

© 2024 Kaiser Permanente